First Light Asset Management LLC lowered its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 1.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 120,941 shares of the biotechnology company’s stock after selling 2,381 shares during the period. BioMarin Pharmaceutical comprises 1.2% of […]
Endurant Capital Management LP decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 42.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 84,357 shares of the biotechnology company’s stock after selling 61,017 shares during the period. BioMarin Pharmaceutical comprises about […]
Grey Fox Wealth Advisors LLC bought a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 302 shares of the biotechnology company’s stock, valued at approximately $31,000. A number of other hedge funds and […]
Utah Retirement Systems decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 0.9% in the 4th quarter, HoldingsChannel reports. The firm owned 32,778 shares of the biotechnology company’s stock after selling 300 shares during the quarter. Utah Retirement Systems’ holdings in BioMarin Pharmaceutical were worth $3,392,000 as of its most recent filing […]
Gyon Technologies Capital Management LP raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 150.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 16,079 shares of the biotechnology company’s stock after buying an additional 9,653 shares during the period. Gyon Technologies […]